Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (2)
  • Antibiotic
    (2)
  • Bcl-2 Family
    (1)
  • Beta Amyloid
    (1)
  • Caspase
    (1)
  • Ferroptosis
    (1)
  • Microtubule Associated
    (1)
  • SARS-CoV
    (1)
  • Topoisomerase
    (1)
  • Others
    (3)
TargetMol | Tags By ResearchField
  • Infection
    (3)
  • Immune System
    (2)
  • Inflammation
    (2)
  • Cancer
    (1)
Filter
Search Result
Results for "

prostatitis

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | All_Pathways
  • Natural Products
    2
    TargetMol | Natural_Products
  • Isotope Products
    1
    TargetMol | Isotope_Products
Verbenalin
Verbenaloside, Verbenalol β-D-glucopyranoside, Verbenalol glucoside, Cornin
T3890548-37-8
Verbenalin (Verbenaloside) induces angiogenesis via a programmed PI3K/Akt/eNOS/VEGF signaling axis.
  • $30
In Stock
Size
QTY
Temafloxacin
Omniflox
T19794108319-06-8
Temafloxacin (Omniflox) is an antibiotic and antimycobacterial agent. It used to treat lower respiratory tract infections, genital and urinary infections like prostatitis, and skin infections.
  • $34
In Stock
Size
QTY
Flumequine-13C3
Flumequine-13C3
T360211185049-09-5
Flumequine-13C3is intended for use as an internal standard for the quantification of flumequine by GC- or LC-MS. Flumequine is a fluoroquinolone antibiotic.1It is active againstS. aureus, S. pyogenes, B. subtilis, E. coli, P. aeruginosa, S. faecalis, andK. pneumoniae(MICs = 1-100 μg/ml). Flumequine is also active against field isolates of B. hyodysenteriae (MICs = 6.25-200 μg/ml).2It inhibits DNA gyrase, disrupting supercoiling of bacterial DNA to block transcription and replication.3In vivo, flumequine (50 mg/kg) increases survival in rat models ofP. vulgaris-induced urinary tract infection andP. mirabilis-induced prostatitis.1Formulations containing flumequine have been used in the treatment of urinary tract infections in veterinary medicine. 1.Rohlfing, S.R., Gerster, J.R., and Kvam, D.C.Bioevaluation of the antibacterial flumequine for urinary tract useAntimicrob. Agents Chemother.10(1)20-24(1976) 2.Aller-Morán, L.M., Martínez-Lobo, F.J., Rubio, P., et al.Evaluation of the in vitro activity of flumequine against field isolates of Brachyspira hyodysenteriaeRes. Vet. Sci.10351-53(2015) 3.Smith, J.T.The mode of action of 4-quinolones and possible mechanisms of resistanceJ. Antimicrob. Chemother.18 (Suppl. D)21-29(1986)
  • $492
35 days
Size
QTY
hTrkA-IN-1
T392661824664-89-2
hTrkA-IN-1 is a potent and orally active inhibitor of TrkA kinase with an IC 50 of 1.3 nM, compound 2.hTrkA-IN-1 can be used for the study of inflammatory disease, such as prostatitis, pelvic, et al.
  • $970
Inquiry
Size
QTY
Methyl 2-O-β-D-glucopyranosylbenzoate
Methyl salicylate 2-O-β-D-glucopyranoside
TN1142910019-60-0
Methyl 2-O-β-D-glucopyranosylbenzoate (Methyl salicylate 2-O-β-D-glucopyranoside) (Compound 11) is a phenolic compound that can be isolated from the leaves of Metapanax delavayi. This compound exhibits anti-benign prostatic hyperplasia activity and significantly inhibits the proliferation of BPH-1 cells. It is applicable for research related to prostatitis.
  • Inquiry Price
10-14 weeks
Size
QTY